A panel (hosted by the LES USA-Canada San Diego Chapter) will present a summary of the findings and value of the 2024 Life Sciences Global Royalty Rate surveys for San Diego Chapter attendees. The 2024 Life Science survey follows a decade of prior surveys, revealing trends in dealmaking, including valuation by technology type and stage of development, detailed consideration of royalty components, milestones, sources, and more. The LES Global Royalty Rate surveys provide exceptional detail not found in other resources.

Special points of interest in Life Science include:

• Assessment of Oncology, Ophthalmology, Respiratory, Blood & Clotting, and Immunological therapies.
• Tiered vs. Flat royalty variations
• Biotechnology tool deal rates
• Comparisons of pre- and post-proof-of-concept valuations